High analytical concordance between a novel companion diagnostic assay and an IUO assay for BRAF V600E/V600K detection in melanoma

被引:0
|
作者
O'Donnell, L. [1 ]
Sweet, W. [1 ]
Lu, X. [1 ]
Meynier, F. [2 ]
Derome, A. [3 ]
Ganee, L. [4 ]
Poyet-Gelas, F. [3 ]
Martin, A. [5 ]
Casey, M. [6 ]
Kertesz, N. [7 ]
机构
[1] BioMerieux Inc, Clin Affairs, Durham, NC USA
[2] BioMerieux Inc, BioMath, Grenoble, France
[3] BioMerieux Inc, V&V, Grenoble, France
[4] BioMerieux Inc, Prod Design & Dev, Grenoble, France
[5] GSK, Oncol, Collegeville, PA USA
[6] GSK, Stat, Collegeville, PA USA
[7] Response Genet Inc, Pharmaceut Liaison Manager, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MC13-0053
引用
收藏
页码:S27 / S27
页数:1
相关论文
共 50 条
  • [21] Clinicopathologic characteristics of BRAF V600K mutant malignant melanoma in comparison with V600E mutant cases: a preliminary study
    Bulbul, G.
    Agalar, A. A.
    Yumuk, E.
    Cagaptay, S.
    Ellidokuz, H.
    Lebe, B.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S130 - S130
  • [22] Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
    Reid, Anna L.
    Freeman, James B.
    Millward, Michael
    Ziman, Melanie
    Gray, Elin S.
    CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 999 - 1002
  • [23] BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes
    Nikanjam, Mina
    Tinajero, Jose
    Barkauskas, Donald A.
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (06) : 1072 - 1079
  • [24] Comparison of BRAF V600E Mutation Detection Between Sanger Sequencing and Companion Diagnostic Methods
    Bender, R.
    Arnold, K.
    Ghazalpour, A.
    McGinniss, M.
    Gatalica, Z.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 741 - 741
  • [25] Pediatric Melanoma With a Rare BRAF V600K Mutation
    Singh, Pragya
    Wu, Daisy
    Karunamurthy, Arivarasan
    Seynnaeve, Brittani K. N.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2025, 47 (02) : 162 - 164
  • [26] An Algorithm to Improve Identification of BRAF V600 Wild Type,V600E, V600K and V600R Mutations Tested by Pyrosequencing
    Shen, S.
    Zhong, Z.
    Qin, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 731 - 731
  • [27] Ursolic acid interaction with transcription factors BRAF, V600E, and V600K: a computational approach towards new potential melanoma treatments
    Aguilera-Duran, Giovanny
    Hernandez-Castro, Stephanie
    Loera-Garcia, Brenda V.
    Rivera-Vargas, Alex
    Alvarez-Baltazar, J. M.
    Cuevas-Flores, Ma Del Refugio
    Romo-Mancillas, Antonio
    JOURNAL OF MOLECULAR MODELING, 2024, 30 (11)
  • [28] A real-time PCR assay for detection of BRAF V600E/K/D mutations in melanoma and colorectal cancer
    Su, H.
    Erickson, B.
    Murray, D.
    Mak, W-B
    Voss, J.
    Brankley, S.
    Kipp, B.
    Halling, K.
    Abravaya, K.
    Huang, S.
    VIRCHOWS ARCHIV, 2014, 465 : S322 - S322
  • [29] BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies
    Zengarini, Corrado
    Mussi, Martina
    Veronesi, Giulia
    Alessandrini, Aurora
    Lambertini, Martina
    Dika, Emi
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (06) : 1131 - 1136
  • [30] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448